Case report| Volume 42, 102105, July 2020

Multiple cervical dissections after Rituximab


      • We report a case of multiple dissections after Rituximab.
      • Accountability of Rituximab cannot be excluded.
      • The cytokine release after Rituximab infusion could be a trigger.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arunprasath P.
        • Dubashi B.
        • Balachander J.
        • Gobu P.
        • Satheesh S.
        Rituximab induced myocardial infarction: A fatal drug reaction.
        Journal of Cancer Research and Therapeutics. 2011; 7: 346
        • Durand-Dubief F.
        • Marignier R.
        • Berthezene Y.
        • Cottin J.
        • Nighoghossian N.
        • Vukusic S.
        Spontaneous multiple cervical artery dissections after alemtuzumab.
        Multiple Sclerosis Journal. 2019 May 9; (135245851982866)
        • Feinstein A.
        • Meza C.
        • Stefan C.
        • Staines R.W.
        Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
        Brain. 2019 Sep 1; 142: 2800-2812
        • Montalban X.
        • Hauser S.L.
        • Kappos L.
        • Arnold D.L.
        • Bar-Or A.
        • Comi G.
        • et al.
        Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
        New England Journal of Medicine. 2017 Jan 19; 376: 209-220
        • Paul F.
        • Cartron G.
        Infusion-related reactions to rituximab: frequency, mechanisms and predictors.
        Expert Review of Clinical Immunology. 2019 Apr 3; 15: 383-389